68Ga-DOTATATE PET/CT in Pituitary Carcinoma

Research output: Contribution to journalArticlepeer-review

7 Citations (Scopus)

Abstract

A 47-year-old woman with atypical pituitary adenoma was referred to the neurosurgery department due to recent back pain. She had multiple transsphenoidal surgery, stereotactic body radiation, and 177Lu-DOTATATE therapy. Her spinal MRI showed multiple spinal masses. The patient underwent 68Ga-DOTATATE PET/CT to confirm the metastatic spread of the disease. PET/CT images showed increased uptake at the local recurrent tumor site and spinal metastases confirmed by biopsy to pituitary carcinoma. Our case presents the role of 68Ga-DOTATATE PET/CT in patients with pituitary carcinoma.

Original languageEnglish
Pages (from-to)996-998
Number of pages3
JournalClinical Nuclear Medicine
Volume46
Issue number12
DOIs
Publication statusPublished - 1 Dec 2021

Keywords

  • Ga-DOTATATE
  • Lu-DOTATATE
  • PRRT
  • pituitary carcinoma
  • theranostic

Fingerprint

Dive into the research topics of '68Ga-DOTATATE PET/CT in Pituitary Carcinoma'. Together they form a unique fingerprint.

Cite this